Comparative sequence analysis of the capsular polysaccharide loci of Actinobacillus pleuropneumoniae serovars 1-18, and development of two multiplex PCRs for comprehensive capsule typing by Bossé, Janine T et al.
Contents lists available at ScienceDirect
Veterinary Microbiology
journal homepage: www.elsevier.com/locate/vetmic
Comparative sequence analysis of the capsular polysaccharide loci of
Actinobacillus pleuropneumoniae serovars 1–18, and development of two
multiplex PCRs for comprehensive capsule typing
Janine T. Bosséa,⁎,1, Yanwen Lia,1, Roberto Fernandez Crespoa, Sonia Lacoutureb,
Marcelo Gottschalkb, Rita Sárközic,1, László Fodorc, Maria Casas Amoribietad, Øystein Angene,
Katerina Nedbalcovaf, Matthew T.G. Holdeng,2, Duncan J. Maskellh, Alexander W. Tuckerh,
Brendan W. Wreni, Andrew N. Rycroftj, Paul R. Langforda, on behalf of the BRaDP1T consortium
a Section of Paediatrics, Department of Medicine, Imperial College London, St. Mary's Campus, London, UK
bGroupe de Recherche sur les Maladies Infectieuses du Porc, Faculté de Médecine Vétérinaire, Université de Montréal, Québec, Canada
c Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary
dOVISLAB S.L., Barcelona, Spain
e Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark
f Veterinary Research Institute, Hudcova 70, 621 00 Brno, Czech Republic
g The Wellcome Trust Sanger Institute, Hinxton, UK
hDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK
i Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK
jDepartment of Pathology and Pathogen Biology, The Royal Veterinary College, Hawkshead Campus, UK
A R T I C L E I N F O
Keywords:
Diagnostic
mPCR
Capsule typing
A. pleuropneumoniae
Serovars
A B S T R A C T
Problems with serological cross-reactivity have led to development of a number of PCRs (individual and mul-
tiplex) for molecular typing of Actinobacillus pleuropneumoniae, the causative agent of porcine pleuropneumonia.
Most of these assays were developed for detection of speciﬁc amplicons within capsule biosynthetic genes before
the availability of complete sequences for the diﬀerent serovars. Here we describe comparative analysis of the
complete capsular loci for all 18 serovars of A. pleuropneumoniae, and development of two multiplex PCRs for
comprehensive capsule typing of this important pig pathogen.
1. Introduction
Pleuropneumonia is an economically important disease causing
considerable losses in the worldwide swine industry (Sassu et al.,
2017). The causative agent, Actinobacillus pleuropneumoniae, can be
diﬀerentiated into 2 biovars based on the requirement for nicotinamide
adenine dinucleotide (NAD-dependent biovar 1; NAD-independent
biovar 2); and subsequently into 18 serovars based on surface poly-
saccharides, mainly capsule (Bossé et al., 2018). The ability to dis-
criminate between serovars is advantageous, as there are diﬀerences in
geographical distribution that are not static (Gottschalk, 2015; Sassu
et al., 2017), as well as diﬀerences in levels of virulence (Klitgaard
et al., 2010). Thus, accurate typing is essential for diagnosis and for
tracking the emergence of serovars rarely, or not previously, reported
within a geographical region.
Although a number of serological tests are available for typing A.
pleuropneumoniae isolates [see (Gottschalk, 2015) for a recent review],
the need for high quality reference antisera limits the number of la-
boratories able to perform diagnostics, and even then, problems with
cross reactivity between certain serovars are unavoidable. Increasingly,
laboratories are using molecular typing methods to more accurately and
reproducibly identify A. pleuropneumoniae isolates (Gottschalk, 2015;
Sassu et al., 2017). PCRs have been developed for detection of speciﬁc
CPS genes in most of the currently recognized 18 serovars (except 4, 9,
11, 13 and 14), either individually or in multiplex reactions, for de-
tection of predominant serovars in a given geographical region (Angen
et al., 2008; Bossé et al., 2014, 2017, 2018; Ito and Sueyoshi, 2015;
Jessing et al., 2003; Schuchert et al., 2004; Turni et al., 2014). Some of
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these PCR assays were developed prior to the availability of whole
genome sequences (wgs), and were based on (sometimes incomplete)
sequences of the CPS biosynthetic loci.
The aim of this study was to comprehensively analyze the complete
CPS loci for all known serovars of A. pleuropneumoniae, and to develop
multiplex PCRs capable of their speciﬁc identiﬁcation.
2. Materials and methods
2.1. A. pleuropneumoniae isolates used in this study
All sequences used in this study are shown in Table 1, with acces-
sion numbers shown for previously published whole genomes and for
the full CPS loci of serovars lacking full genome sequences in Genbank.
In this study, wgs data was generated for the reference strains of ser-
ovars 13 (N273), 14 (3906), and 15 (HS143), and for two isolates of
K2:O7 (7317/84 and 9712534), as previously described (Bossé et al.,
2018). The regions of whole genome sequences containing the complete
CPS loci (export and biosynthetic genes) were identiﬁed initially by
using tBLASTn (http://blast.ncbi.nlm.nih.gov /Blast.cgi) to identify the
cpxD gene (accession AIA09380) common to all A. pleuropneumoniae
serovars. The complete CPS loci, found between the genes modF and
ydeN in all serovars, were extracted for further analysis using BLASTn
and BLASTx. Multiple sequence alignments were performed using
ClustalW, and a schematic representation of each locus was generated
using Gene Graphics (Harrison et al., 2017), with a Neigbour-Joining
tree constructed using the Tamura-Nei algorithm with 1000 bootstraps
(Fig. 1).
The complete capsule loci (with ﬂanking sequences modF and ydeN)
for the reference strains of serovars 13–16, and for the two isolates of
K2:O7 (7317/84 and 9712534) have been deposited in GenBank under
accession numbers MG868947 to MG868952.
2.2. Diagnostic PCRs
The primer pairs used in APP-mPCR1 for speciﬁc detection of ser-
ovars 1–12 and 15, along with the common apxIV amplicon used in
previous mPCRs for species level detection of A. pleuropneumoniae, are
shown in Table 2. Some of the primer pairs were used in our previous
mPCR (Bossé et al., 2014), whereas new pairs were designed, either to
improve speciﬁcity for previously tested serovars (e.g. 3, 6, 7, and 8), or
for serovars not previously included in our mPCR. All primers were
designed to amplify sequences speciﬁc to the relevant serovar, with
generation of amplicons of diﬀerent sizes to allow suﬃcient separation
of all amplicons by gel electrophoresis in 1.5% agarose. The speciﬁcity
of all primers were initially tested in individual PCRs using genomic
DNA from the homologous serovar reference strains, followed by in-
corporation of all primers into multiplex format, using the Qiagen
Multiplex PCR Plus kit as previously described (Bossé et al., 2014). APP-
mPCR1 was then tested with all of the 18 A. pleuropneumoniae serovar
reference strains (i.e. 4074T, 1536, S1421, M62, K17, L20, Femø, WF83,
405, CVJ13261, D13039, 56153, 8328, N-273, 3906, HS143, A-85/14,
16287-1, and 7311555, respectively), as well as a set of clinical isolates
comprising 2–5 isolates of each of the 18 A. pleuropneumoniae serovars,
and 31 other porcine-associated bacterial species, used in previous
studies (Bossé et al., 2017; 2018). Furthermore, as our previous mPCR
(Bossé et al., 2014) was found to detect both serovar 2 and 8 amplicons
using DNA from the K2:O7 isolates 7317/84 and 9712534, we speci-
ﬁcally compared our new APP-mPCR1 to our previous mPCR for de-
tection of speciﬁc amplicons from these two isolates.
The primer pairs used in APP-mPCR2 for speciﬁc detection of A.
pleuropneumoniae serovars 13–14, and 16–18, along with the species
speciﬁc apxIV amplicon and the full length nadV gene found in biovar 2
isolates, are shown in Table 3. The speciﬁcity of these primers was
evaluated as for the mPCR1 primers above.
3. Results and discussion
Initial analyses of the CPS loci in publically available genomes of A.
pleuropneumoniae (Table 1) revealed that sequences previously de-
posited in Genbank as Shope 4074 (accession AACK00000000) and
N273 (accession ADOM00000000) appear to be incorrect, having CPS
loci matching serovars 5 and 7, respectively. The serovar 1 CPS locus is
found in the genome of Shope 4074 (accession ADOD00000000), as
well as in the recently closed genome of strain KL 16 (accession
CP022715) (Xu et al., 2010; Park et al., 2017). The correct serovar 13
CPS locus (accession number MG868947) was identiﬁed in the draft
genome of N273 that was generated as part of this study, and although
similar to the serovar 7 locus (Fig. 1), the cps13D gene encodes a pre-
dicted protein that shares only 43% identity with that of the Cps7D
CDP-glycerol-glycerophosphate glycerophosphotransferase protein.
Furthermore, the cps13E gene shows no homology to any other se-
quence in Genbank at the nucleotide level, and the encoded protein
shares limited identity (< 35%) with hypothetical proteins from var-
ious Gram-positive species (e.g. accession number WP_010632822).
Although sequences for the CPS loci of serovars 14, 15, and 16 have
previously been deposited in Genbank (accession numbers AB810251,
AB701753, KX907602), we have extended these sequences (accession
numbers MG868948, MG868949, MG868950) to encompass the com-
plete CPS loci in order to allow a more thorough comparison with the
other serovars. Additionally, we have generated draft genomes of two
serovar K2:O7 isolates in order to compare their CPS loci (accession
numbers MG868951 and MG868952) to those in the two published
serovar 2 genomes (accession numbers ADXN00000000 and
ADOE00000000) (Xu et al., 2010; Zhan et al., 2010). Although the
genes in the K2:O7 CPS loci encode the same proteins as in the serovar 2
CPS loci, there are diﬀerences at the nucleotide level that explain am-
pliﬁcation of both serovar 2 and 8 amplicons for K2:O7 isolates using
our previously designed mPCR (Bossé et al., 2014). In that assay, the
serovar 8 primers were designed to amplify an 1106 bp fragment
spanning parts of the cpsAB genes, and were speciﬁc when tested using
a large number of clinical isolates, including 45 serovar 2 and 115
serovar 8 isolates (Bossé et al., 2014), however no K2:O7 isolates were
Table 1
Accession numbers for APP sequences used in this study.
Serovar Strain Accession Reference
1 4074a ADOD00000000 Xu et al. (2010)
1 KL 16 CP022715 Park et al. (2017)
2 4222 ADXN00000000 Zhan et al. (2010)
2 S1536 ADOE00000000 Xu et al. (2010)
K2:07 7317/84 MG868951 This study
K2:07 9712534 MG868952 This study
3 JL03 CP000687 Xu et al. (2008)
4 M62 ADOF00000000 Xu et al. (2010)
5b L20 CP000569 Foote et al. (2008)
6 Femø ADOG00000000 Xu et al. (2010)
7 AP76 CP001091
7 S8 ALYN00000000 Li et al. (2012)
8 MIDG2331 LN908249 Bossé et al. (2016)
9 CVJ13261 ADOI00000000 Xu et al. (2010)
10 D13039 ADOJ00000000 Xu et al. (2010)
11 56153 ADOK00000000 Xu et al. (2010)
12 1096 ADOL00000000 Xu et al. (2010)
13 N273 MG868947 This study
14 3906 MG868948 This study
15 HS143 MG868949 This study
16 A-85/14 MG868950 This study
17 16287-1 MG780416 This study
18 7311555 MG780423 This study
The genome listed as serovar 13 str. N273, accession number ADOM00000000,
is actually a serovar 7 isolate.
a The genome listed as serovar 1 str. 4074, accession number
AACK00000000, is actually a serovar 5 isolate.
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tested at that time. Furthermore, we recently found that these serovar 8
primers also produced amplicons from some, but not all, serovar 17
isolates (Bossé et al., 2018). Before redesigning new primers for speciﬁc
detection of serovar 8, as well as designing primers for detection of
speciﬁc capsule genes in serovars 4, 9, 11, and 14 (for which there are
currently no molecular diagnostics), we thoroughly analysed the com-
plete CPS loci of all known A. pleuropneumoniae serovars.
In each serovar, the complete CPS locus is found between the genes
modF, encoding a putative molybdenum transport ATP-binding protein,
and ydeN, encoding a predicted serine hydrolase (Fig. 1). The CPS ex-
port genes, cpxABCD, are transcribed divergently from the CPS bio-
synthetic genes for all but serovar 15, where the export genes are im-
mediately downstream of the biosynthetic genes, in the same
orientation (Ito and Sueyoshi, 2014). The organization of the CPS ex-
port genes next to the biosynthetic genes is similar in other members of
the Pasteurellaceae, as well as in other Gram-negative bacteria, such as
Escherichia coli and Neisseria meningitidis, suggesting a common mole-
cular origin for these loci (Boulnoisl and Jann, 1989; Frosch et al.,
1991; Lâm et al., 2011). In many of these bacteria, a third region
containing genes involved in post-polymerization modiﬁcations/trans-
port is found on the other side of the biosynthetic locus, such that the
central biosynthetic genes (region II) are variable, whilst the ﬂanking
regions I and III are constant in a given species (Boulnoisl and Jann,
1989; Frosch et al., 1991). In A. pleuropneumoniae, only regions I and II
are contiguous, whereas genes encoding proteins sharing 63% and 66%
identity, respectively, with HcsA and HcsB (encoded by region III of
Haemophilus inﬂuenzae) are found elsewhere in the chromosome (ac-
cession numbers WP_039709373 and WP_005610771).
The CPS biosynthetic loci of the diﬀerent A. pleuropneumoniae ser-
ovars can be grouped into four types (Fig. 1), with common core genes
identiﬁed in each for types I-III, and type IV only found in serovar 16
(Xu et al., 2010; Bossé et al., 2017). The most common are the type I
loci, found in serovars 2, 3, 6, 7, 8, 9, 11, 13, and 17 (Xu et al., 2010;
Bossé et al., 2018), which produce teichoic acid-type polymers with
phosphodiester linkages joining repeating glycosyl-glycitol units (Perry
et al., 1990; MacLean et al., 2004). The core cpsABC genes of the type I
loci are well conserved, sharing a minimum of 88% identity, and en-
code a CDP-glycerol glycerophosphotransferase, a glycerol-3-phosphate
cytidylyltransferase, and a protein of unknown function, respectively.
Although less well conserved, the type I cpsD genes all encode proteins
with a glycosyl transferase domain (pfam04464) and a glycosyl trans-
ferase group 1 domain (either pfam00534 or pfam13692), that are,
along with the products of the cpsABC genes, predicted to be involved in
synthesis of the teichoic acid-type polymers characteristic of type I
CPSs. In serovar 3, the cpsD gene has been split into two open reading
frames due to an internal stop codon. It is not known if the second orf
Fig. 1. Schematic comparison of the complete capsule loci of A. pleuropneumoniae serovars 1–18 and K2:O7. The capsule loci are arranged according to phylogenetic
similarity, as indicated by the tree on the left, and are clustered into their respective CPS types (I–IV) as indicated by the labeled brackets. All loci are ﬂanked by the
modF gene at the start (white arrow in shaded grey box; note an internal stop codon is present in the serovar 6 modF sequence), and ydeN at the end, preceded either
the by the 552–555 bp hypothetical gene or the 114 bp hypothetical and partial lysA genes (white arrow, preceded by either mauve or brown arrows, respectively, in
shaded grey box). The capsule export genes, cpxABCD, are indicated as reverse oriented arrows shaded black to light grey, respectively. The genes of the respective
serovar CPS biosynthetic loci are named as follows: cps2ABCDEFG (for both K2:O7 and serovar 2); cps7ABCDE, cps13ABCDE, cps3ABCDD’EF, cps11ABCDEF,
cps9ABCDEF, cps6ABCDEFG, cps17ABCDEF, cps8ABCDEFGH, cps16ABCDEF, cps10ABCD kdsAB kpsF, cps5ABC kdsAB kpsF, cps15ABC, cps4ABC, cps12ABB’,
cps18ABC,cps14AB1B2B3CDEFG, cps1ABCD. The core cpsABC genes conserved in all of type I CPS loci are indicated as the dark, medium, and light blue arrows,
respectively (note the extra gene at the start of the serovar 7 biosynthetic locus, shown as a striped arrow, indicates the ISApl1 insertion present in the AP76 strain,
and is not part of the biosynthetic locus). The cpsD genes in the type I loci are indicated in diﬀerent shades of teal, according to similarity greater than 50% identity
(note in serovar 3, an internal stop codon has resulted in two orfs, cps3D and cps3D’). In serovars 6, 17 and 8, the cpsE genes share> 80% identity and are shown as
bright green arrows; and the last gene in the serovar 8 locus, cps8H, shares 94% identity with the C-terminal half of the serovar 17 cpsF gene, as indicated by the olive
shaded arrows in the respective loci. The core genes in the type III CPS loci (kdsAB and kpsF) are indicated by the dark red, bright red, and pink arrows, respectively,
at the ends of the serovar 5 and 10 loci. In the type II loci, the conserved core cpsA gene is shown as a yellow arrow. The white arrows in each biosynthetic locus
indicate genes unique to each serovar. As expected, the K2:O7 CPS locus shares 96% identity across the entire sequence with that of serovar 2 (with nucleotide
diﬀerences being mainly found in the cpsABC genes), and the speciﬁc cps2EFG genes found at the ends of both of these loci are boxed. Serovars 9 and 11 share 99%
identity across their cpsEF genes (also shown boxed), with only a single nucleotide diﬀerence resulting in an alternate start codon for the cpsF gene in each locus. The
Neighbour-Joining tree shown at the left of the ﬁgure was constructed using the Tamura-Nei algorithm with 1000 bootstraps, and the width of the line underneath it
shows a 5% nucleotide diﬀerence (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article).
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(cpsD’) is translated, as there is no obvious ribosomal binding site
preceding the start. The sequences spanning cpsD and cpsD’ in serovar 3
share 86% identity with the cpsD genes found in serovars 9 and 11; the
cpsD gene from serovar 2 shares 76% identity with that of serovar 7, but
only 56% with that of serovar 13; and the cpsD gene from serovar 8
shares 96% and 98% identity with those from serovars 6 and 17, re-
spectively. Serovars 6, 8 and 17 further share a common cpsE gene (84%
identity for the serovar 6 gene compared to the serovar 8 and 17 genes,
which share 99% identity). Additionally, the last gene of the serovar 8
locus (cps8H) shares 90% identity with the ﬁnal 911 bases of the 1548
bp cps17F gene, as previously noted (2).
Type II loci are found in serovars 1, 4, 12, 14, 15, and 18 (Xu et al.,
2010; Ito and Sueyoshi, 2014; Ito, 2015; Bossé et al., 2018), and pro-
duce repeating oligosaccharide polymers with phosphate linkages, as
shown for serovars 1, 4, 12, and 15 (Perry et al., 1990; 2011). The
conserved cpsA genes in these loci (99% identical for all but cps15A,
which shares only 65% identity) all encode a capsular polysaccharide
phosphotransferase which likely mediates the phosphate linkages
characteristic of type II CPSs. Serovars 5 and 10 have type III loci and
produce glycosidically linked sugar polymers (Perry et al., 1990), with
the common core genes (kdsA, kdsB and kpsF, found at the 3′ end of
theses loci) encoding 2-dehydro-3-deoxyphosphooctonate aldolase, 3-
deoxy-manno-octulosonate cytidylyltransferase, and arabinose 5-phos-
phate isomerase, respectively. The serovar 16 CPS locus (type IV) is
entirely unique (Bossé et al., 2017), and the structure of this CPS has
not yet been determined.
All of the type II loci have a 114 bp orf followed by a partial lysA
gene (of varying length) upstream of ydeN (Fig. 1) that are not likely
involved in CPS synthesis. These sequences are also found in the type I
loci of serovars 8 and 17; whereas all the remaining serovars with type
I, III and IV loci, have a 552–555 bp gene encoding a hypothetical
protein of unknown function (though again, not likely involved in CPS
synthesis) immediately upstream of ydeN, except for the serovar 6 re-
ference strain Femø, where ydeN immediately follows the last cps gene
Table 2
APP-mPCR1 primers for detection of serovars 1–12 and 15.
Primer name Sequence Target genea Amplicon size Reference or source
AP1F CTGGAGTAATTACGGCGACTATTCC cps1B 959 Bossé et al. (2014)
AP1R AGGAGAAGCTAGTAGTACTTGCATTTTC cps1B
AP2F GAGTGTGATGATGATGCTCTGGTTC cps2E 247 Bossé et al. (2014)
AP2R TACCAATAACTGTTGCAACTAACGC cps2E
AP3F TTGTAGAGCCCGCCAGATTTACG cps3F 500 This study
AP3R CATTCGCACCAGCAATCACC cps3F
AP4F CAGCATGGGTTTGGTCCTGTTG cps4B 204 This study
AP4R GGCTTTCTCCGTGTATGAATAAAGTG cps4B
AP5F AGCCACAAGACCCGAATGGTATAATG cps5B 825 Bossé et al. (2014)
AP5R CCATCAAATGCAGCTTCAAGGAGC cps5B
AP6F TGACTGGCTTCGTGAAAATGAG cps6F 718 This study
AP6R GTCTGAAGTTTTATTCGCAGCTCC cps6F
AP7F TTGGAATGGATTCATGATTGGGC cps7E 601 Bossé et al. (2014)
AP7R CGGAAATGGCCTATTGAAAAACG cps7E
AP8F ACATCCAAGCCGTTCTCCAG cps8F 1126 This study
AP8R CATCCATGAGCCAATGAGGG cps8G
AP9F GTAGGACGTGGTAACATTGAGGC cps9E 2105 This study
AP9R ACGGGTGCAATTTCTAAAGCTG cps9F
AP10F GGTGGTGATGGAACAAGGTTATGG cps10A 183 Bossé et al. (2014)
AP10R CTGTAATTGATGCGAAATAGTAGATTGGTGC cps10A
AP12F TAAAGGTATTATAACGCCGGCTCT cps12A 347 Bossé et al. (2014)
AP12R CTCCCATCTGTTGTCTAAGTAGTAG cps12A
AP15F GCAACTTGGAGAACATGGTTAAATCAAG cps15B 1595 This study
AP15R CAACCCTCCAATGTAAGCGAAGG cps15C
apxIVA1 TTATCCGAACTTTGGTTTAGCC apxIV 418 Zhou et al. (2008)
apxIVA3 CATATTTGATAAAACCATCCGTC Intergenicb
a For each serovar capsule locus, the biosynthetic genes are labeled alphabetically starting from A in each case.
b Intergenic region immediately downstream of apxIVA.
Table 3
APP-mPCR2 for detection of serovars 13, 14, and 16–18.
Primer name Sequence Target genea Amplicon size Reference or source
AP13F GTTGTGTATCGAGGTTGGCATTTC cps13E 665 This study
AP13R ATGTAAAGGATCTAAGCCGTGTG cps13E
AP14F TGCATTACGCTTATATTCTGAATGG cps14G 1911 This study
AP14R TTGTCGATCGAGAGGGAGTAACG ydeN
AP16F TTACTCACTTGGGCTAGGGATAG cps16C 212 Bossé et al. (2017)
AP16R ACCAGCAATATGATTACGCCC cps16D
AP17F TTGTAATGGCGGTGTAATGCTAC cps17F 302 Bosse et al. (2018)
AP17R CATAAGTGCAGCCATCTCTTTCAG cps17F
AP18F CGGAGTTTGGCAGCATAAAGG cps18B 514 Bosse et al. (2018)
AP18R CCATAATCGGTGCTCAACTAAGAATG cps18B
nadVF CTCACTAAACAAAACTCTGCGTTC nadV 1339 This study
nadVR TTCGGATGACAGAACTTTTACCCG nadV
apxIVA1 TTATCCGAACTTTGGTTTAGCC apxIV 418 Zhou et al. (2008)
apxIVA3 CATATTTGATAAAACCATCCGTC Intergenicb
a For each serovar capsule locus, the biosynthetic genes are labelled alphabetically starting from A in each case.
b Intergenic region immediately downstream of apxIVA.
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(Fig. 1). These genes preceding ydeN delineate the 3′ boundaries of the
diﬀerent CPS biosynthetic loci in A. pleuropneumoniae, and give an in-
dication of possible evolutionary origins.
There are terminal inverted repeats (IRs) of 35–46 bp, containing a
central IR sequence, ﬂanking all of the A. pleuropneumoniae capsule loci
that end with the 114 bp orf and partial lysA gene. Along with the
atypically low GC content of the A. pleuropneumoniae CPS loci (espe-
cially the biosynthetic genes that have GC contents around 10% lower
than respective genomes), the presence of IRs at the boundaries are
indicative of the CPS loci being insertion elements acquired by hor-
izontal transfer (Darmon and Leach, 2014). All A. pleuropneumoniae
serovars, regardless of capsule type, have at least part of the 46 bp
sequence TAAAGGAAATCCCCc/tTCTTTAGTAAAGAGGGg/aTTAGGGG
AGATTTG
(lower case letters indicating diﬀerences in some serovars at these
bases; IR sequence underlined) downstream of modF, along with an
almost perfect repeat of the central IR (CCCCTCTTTGCTAAAGAGGGG)
close to the 3′ end of cpxA, suggesting it may be a rho-independent
terminator for this gene. In serovars 1, 9, 11, and 18, there may have
been recombination between the two copies of the IR such that only a
single copy is found, with 35 of the 46 bp sequence conserved (TAAA
GGAAATCCCCCTCTTTAGTAAAGAGGGGGGAT) upstream of cpxA in
these serovars. An almost identical, but inverted, 46 bp sequence (
CAAATCTCCCCTATCc/aCCTCTTTACTAAAGAGGGGg/aATTTCCTTTA)
is found downstream of the ﬁnal CPS biosynthetic gene in all loci that
are followed by the 114 bp orf and partial lysA gene, whereas in ser-
ovars with CPS loci followed by a 552–555 bp gene, no evidence of this
sequence is seen. These data suggest that, in A. pleuropneumoniae, a type
II CPS locus was the ﬁrst to be acquired by horizontal transfer, with
subsequent diversiﬁcation of the other biosynthetic loci via gene dele-
tion and/or acquisition of other capsule genes by horizontal transfer
and homologous recombination via conserved ﬂanking sequences.
The A. pleuropneumoniae serovar 14 type II CPS locus was previously
shown to be almost identical to that found in Actinobacillus suis K1
strains such as ATCC 33415 (accession CP009159) (Ito, 2015). As in A.
pleuropneumoniae, the CPS export genes in A. suis are downstream of
modF. The biosynthetic genes in A. suis are followed by the same 114 bp
orf as in the A. pleuropneumoniae type II CPS loci. However, in A. suis,
this orf is followed by a complete lysA gene (1251 bp), and three further
genes (gst, hemN, and a 600 bp gene encoding a putative nucleoside-
diphosphate-sugarepimerase), prior to the ydeN gene. This variation in
gene arrangement allows diﬀerentiation of these two species by diag-
nostic PCR (see below). In A. pleuropneumoniae, the ﬁve genes found
upstream of ydeN in A. suis are found elsewhere in the genome
(downstream of frdD). These data suggest that A. pleuropneumoniae
serovar 14 may have acquired the A. suis CPS locus en bloc, with the
resulting duplication of the 114 bp orf and part of the lysA gene. The
other A. pleuropneumoniae serovars with type II CPS loci have reduced
complexity of CPS genes compared to serovar 14, with only the cpsA
gene conserved, and the other genes speciﬁc for each serovar.
Previously, the most complex mPCR for typing of A. pleur-
opneumoniae contained primers for detection of serovars 1–3, 5–8, 10
and 12, with the addition of primers for apxIV to allow detection of
other serovars not included (Bossé et al., 2014). Now, with a total of 18
serovars, plus the species-speciﬁc apxIV amplicon, it was technically
challenging to accurately resolve all of the products in a single mPCR.
We therefore developed two mPCRs (APP mPCR1 and APP mPCR2),
with the ﬁrst capable of detecting serovars 1–12 and 15, and the second
for detection of serovars 13, 14, and 16–18. All primer sequences for
APP mPCR1 and APP mPCR2 are shown in Tables 2 and 3. To reduce
the risk of non-speciﬁc priming, all primers were designed to have a Tm
of 58–63 °C.
We kept some of the primer pairs from our previous 9-serovar mPCR
(Bossé et al., 2014), including those for detection of serovars 1, 2, 5, 10
and 12, but revised our selection of primers for serovars 3, 6, 7, and 8 in
order to target the more serovar-speciﬁc genes towards the end of these
biosynthetic loci. To maintain good size separation of products in the
revised mPCR, the new serovar 3, 6, 7, and 8 primers were designed to
produce similar sized amplicons as the previous primer pairs. To this
new mPCR (APP mPCR1), we added primers for detection of a 1595 bp
fragment spanning the cpsBC genes of serovar 15. As there have not
previously been diagnostic PCRs for the capsule genes of serovars 4, 9,
or 11, we analyzed their biosynthetic loci in order to ﬁnd appropriate
speciﬁc priming sites. For serovar 4, primers were designed to amplify a
unique 204 bp sequence at the 3′ end of the cpsB gene. Alignments of
the complete CPS loci (including the export genes and ﬂanking se-
quences to modF and the 555 bp gene) of the serovar 9 and 11 reference
strains revealed the only diﬀerence is a single base deletion in the ﬁnal
cps gene in serovar 11, such that the reading frame ahead of the dele-
tion shifted to use an alternate start codon. In serovar 9, the cpsF gene is
1146 bp, and that of serovar 11 is 1242 bp. The encoded proteins have
the same C-terminal 349 AAs. It is possible that the altered N-terminal
AAs are responsible for the slight diﬀerences in the CPS structures of
these serovars reported by Perry et al. (Perry et al., 1990). These ser-
ovars also share an almost identical LPS O-antigen (Perry et al., 1990),
and serologically, it is diﬃcult to distinguish serovars 9 and 11. As these
serovars also produce the same complement of Apx toxins (Frey, 1995),
there may be little value in distinguishing them. The primers we have
designed for combined detection of serovars 9/11 amplify a 2105 bp
fragment spanning their cpsEF genes.
The new APP-mPCR1 detects amplicons from serovars 1–12 and 15,
ranging in size from 204 to 2105 bp, plus the 418 bp apxIV amplicon as
an internal control for detection of all A. pleuropneumoniae serovars, as
shown for each of the A. pleuropneumoniae reference strains tested
(Fig. 2). The speciﬁcity of this mPCR was further demonstrated using
DNA prepared from our collection of clinical A. pleuropneumoniae
Fig. 2. Serovar-speciﬁc detection of amplicons from A.
pleuropneumoniae serovars 1–12 and 15 by APP mPCR1.
An apxIV (418-bp) amplicon is detected in all 18 serovar
reference strains. Lane M contains molecular size markers
(100-bp Plus DNA Ladder; Invitogen). Lanes 1 to 18 con-
tain the following strains: 1, 4074 T; 2, S1536; 3, S1421; 4,
M62; 5, L20; 6, Femø; 7, WF83; 8, 405; 9, CVJ13261; 10,
D13039; 11, 56153; 12, 8329; 13, N-273; 14, 3906; 15,
HS143; 16, A-85/14; 17, 16287-1; 18, 7311555.
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isolates, other Actinobacillus species, other Pasteurellaceae, and other
major pathogens of pigs, in addition to virtual PCRs using all available
genomes of the species investigated, where available, as previously
described (Bossé et al., 2017). All A. pleuropneumoniae isolates produced
the 418 bp apxIV amplicon in addition to the appropriate serovar-spe-
ciﬁc bands for each of serovars 1–12 and 15. Furthermore, DNA from
the K2:O7 isolates 7317/84 and 9712534, that produced amplicons for
both serovars 2 and 8 (and apxIV) with our previous 9-serovar mPCR,
produced only the serovar 2 and apxIV amplicons in the new APP-
mPCR1 (Fig. 3). All non-A. pleuropneumoniae isolates were negative for
all amplicons (data not shown).
For development of the new APP-mPCR2, we combined the same
apxIV primers used in APP-mPCR1 with our previously designed pri-
mers for detection of the most recently identiﬁed serovars 16, 17 and 18
(212, 302, and 514 bp amplicons, respectively) (Bossé et al., 2017;
2018). To this mPCR, we added primers for detection of serovars 13 and
14. As mentioned at the beginning of this discussion, the serovar 13 CPS
locus contains a unique gene, cps13E, not seen in any other sequenced
bacterium, so we designed primers to detect a 665 bp fragment of this
gene. The analysis of the serovar 14 CPS locus, as discussed above,
indicated that primers designed to detect any of the cps genes would
also detect the related swine pathogen, A. suis. However, by designing
primers to amplify a 1911 bp fragment from cps14G to ydeN, it is
possible to diﬀerentiate this sequence from A. suis, where the ydeN gene
is almost 6 kb downstream of the ﬁnal cps gene. Since serovars 13, 14,
and 17 are predominantly biovar 2, with biovar 1 isolates also reported
for serovars 13 and 17 (Bossé et al., 2018; Gottschalk, 2015; Sassu et al.,
2017), we added primers for detection of a 1339 bp fragment of the
nadV gene, which confers NAD-independence.
Thus, the new APP-mPCR2 detects amplicons for apxIV, nadV, and
serovars 13–14 and 16–18, ranging in size from 212 to 1911 bp.
Speciﬁc detection of these amplicons was demonstrated using DNA
from each of the A. pleuropneumoniae reference strains (Fig. 4), as well
as the same set of samples used above for validation of the APP-mPCR1.
Again, all non-A. pleuropneumoniae isolates were negative for all am-
plicons (data not shown). Comparison of biovar 1 and 2 isolates of
serovar 17 show that the inclusion of the nadV primers in this mPCR
facilitate diﬀerentiation of these isolates (Fig. 4). Lack of detection of a
nadV amplicon in NAD-independent non-A. pleuropneumoniae isolates,
such as A. suis, indicates that the primer sequences used are speciﬁc for
the A. pleuropneumoniae nadV gene.
In conclusion, we have developed two mPCRs, APP-mPCR1 and
APP-mPCR2, for speciﬁc detection of all 18 known serovars of A.
pleuropneumoniae. Inclusion of primers for detection of apxIV in both
mPCRs provides an internal control for species-speciﬁc detection of all
A. pleuropneumoniae serovars. In general, we would recommend testing
samples with APP-mPCR1 ﬁrst. Any samples producing a positive apxIV
band, but none of the amplicons for serovars 1–12 or 15, should then be
tested using APP-mPCR2.
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Fig. 3. Comparison of previous mPCR (8), and new APP mPCR1 for detection of
A. pleuropneumoniae serovars 2, 8, and K2:O7. The K2:O7 isolates (7317/84 in
lane 1; 9712534 in lane 2) produced amplicons indicative of both serovars 2
and 8 with the previous mPCR (A), but only the correct serovar 2 amplicon with
APP mPCR1 (B). Lanes 3 and 4 contain serovar 2 strain S1536 and serovar 8
strain 405, respectively. Lane M contains molecular size markers (100-bp Plus
DNA Ladder; Invitogen).
Fig. 4. Serovar-speciﬁc detection of amplicons from A.
pleuropneumoniae serovars 13–14 and 16–18 by APP
mPCR2. An apxIV (418-bp) amplicon is detected in all 18
serovar reference strains, and an additional 1339 bp nadV
amplicon is detected only in the biovar 2 strains. Lane M
contains molecular size markers (100-bp Plus DNA Ladder;
Invitogen). Lanes 1 to 18 contain the following strains: 1,
4074 T; 2, S1536; 3, S1421; 4, M62; 5, L20; 6, Femø; 7,
WF83; 8, 405; 9, CVJ13261; 10, D13039; 11, 56153; 12,
8329; 13, N-273; 14, 3906; 15, HS143; 16, A-85/14; 17,
16287-1; 18, 7311555. Lane 19 contains the biovar 2
serovar 17 isolate, 14-022, and Lane 20 contains A. suis
CCM 5586T.
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